פאגאינטרון מזרק מוכן לשימוש 80 מק"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

PEGINTERFERON ALFA 2B 80 MCG / 0.5 ML

MAH:

MERCK SHARP & DOHME ISRAEL LTD

ATC_code:

L03AB05

pharmaceutical_form:

POWDER FOR SOLUTION FOR INJECTION

administration_route:

S.C

manufactured_by:

SCHERING-PLOUGH (BRINNY) IRELAND

therapeutic_group:

INTERFERON ALFA-2B

therapeutic_indication:

Peg- Intron is indicated for the treatment of adult patients with histologically proven chronic hepatitis C who have elevated transaminases without liver decompensation and who are positive for serum HCV-RNA or anti-HCV including naive patients with clinically stable HIV coinfection. The best way to use Peg- Intron in this indication is in combination with ribavirin. This combination is indicated in naive patients including patients with clinically stable HIV co-infection and in patients who have failed previous treatment with interferon alpha (pegylated or nonpegylated ) and ribavirin combination therapy or interferon alpha monotherapy. Interferon monotherapy including Peg-Intron is indicated mainly in case of intolerance or contraindication to ribavirin. Please refer also to the ribavirin physician's insert when Pegintron is to be used in combination with ribavirin.

authorization_date:

2009-02-01